11/14/2024 3:53 PM | Nantahala Capital Management, LLC (Filed by) Soleno Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
11/14/2024 8:36 AM | Avoro Capital Advisors LLC (Filed by) Soleno Therapeutics (Subject)
| Form SC 13G | |
11/12/2024 8:33 AM | Adage Capital Management, L.P. (Filed by) Soleno Therapeutics (Subject)
| Form SC 13G/A | |
11/06/2024 3:06 PM | Soleno Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/24/2024 3:44 PM | BlackRock, Inc. (Filed by) Soleno Therapeutics (Subject)
| Form SC 13G | |
10/21/2024 3:30 PM | Abingworth Bioventures VII LP (Reporting) Soleno Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024 3:31 PM | Carlyle Group Inc. (Filed by) Carlyle Group Inc. (Filed by) Soleno Therapeutics (Subject)
| Form SC 13D/A | |
|
10/15/2024 3:31 PM | Carlyle Group Inc. (Filed by) Carlyle Group Inc. (Filed by) Soleno Therapeutics (Subject)
| Form SC 13D/A | |
10/10/2024 3:30 PM | Carlyle Group Inc. (Filed by) Carlyle Group Inc. (Filed by) Soleno Therapeutics (Subject)
| Form SC 13D/A | |
10/03/2024 4:53 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 4:55 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 5:02 PM | Mackaness James H (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 5:03 PM | Soleno Therapeutics (Issuer) Yen Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 8:55 AM | JANUS HENDERSON GROUP PLC (Filed by) Soleno Therapeutics (Subject)
| Form SC 13G | |
09/10/2024 5:30 PM | Carlyle Group Inc. (Filed by) Carlyle Group Inc. (Filed by) Soleno Therapeutics (Subject)
| Form SC 13D/A | |
09/05/2024 5:37 PM | Soleno Therapeutics (Subject) Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G | |
08/30/2024 5:33 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2024 5:34 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2024 5:35 PM | Mackaness James H (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2024 5:36 PM | Soleno Therapeutics (Issuer) Yen Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2024 6:36 PM | Soleno Therapeutics (Issuer) Vivo Opportunity Fund Holdings, L.P. (Reporting) Vivo Opportunity, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2024 6:14 PM | Soleno Therapeutics (Issuer) Urbanski Raymond W. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/23/2024 6:16 PM | Soleno Therapeutics (Issuer) Urbanski Raymond W. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2024 5:16 PM | Bir Dawn Carter (Reporting) Soleno Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/16/2024 5:18 PM | Bir Dawn Carter (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 5:55 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 5:56 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 5:56 PM | Mackaness James H (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 5:57 PM | Soleno Therapeutics (Issuer) Yen Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 4:18 PM | Soleno Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 3:54 PM | Soleno Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/07/2024 3:00 PM | Soleno Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/19/2024 4:02 PM | Soleno Therapeutics (Filer)
| Form 424B5 | |
07/19/2024 4:04 PM | Soleno Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/19/2024 8:00 AM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 8:01 AM | Soleno Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/19/2024 8:01 AM | Mackaness James H (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 8:02 AM | Hirano Patricia C (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 8:02 AM | Soleno Therapeutics (Issuer) Yen Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 8:03 AM | Huang Michael F. (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 8:04 AM | Manning Meredith (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
The Tesla Trade Is Back In Business (Ad) If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows…
But according to our one expert, new yearly highs are on the horizon…
In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker.
Which is why we’re emailing you now…
You see, most people will simply buy shares of Tesla ahead of the election…
But as they say “There is more than one way to skin a cat”
In fact, we’ve found another way to play shares of Tesla. Discover how to trade Tesla, simply follow this link here. |
07/03/2024 4:56 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 4:58 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 4:58 PM | Mackaness James H (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 5:00 PM | Soleno Therapeutics (Issuer) Yen Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 4:13 PM | Melincoff Gwen A (Reporting) Soleno Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024 3:17 PM | Soleno Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/10/2024 7:49 PM | MARIO ERNEST (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 7:50 PM | Pauls Matthew (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 7:51 PM | Sinclair Andrew (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 7:52 PM | Soleno Therapeutics (Issuer) Volck Birgitte (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 7:46 PM | Harris William G (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 3:29 PM | Soleno Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/23/2024 6:11 PM | MARIO ERNEST (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 4:28 PM | Soleno Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/01/2024 12:07 PM | Soleno Therapeutics (Subject) Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13D/A | |
05/01/2024 12:10 PM | Soleno Therapeutics (Issuer) Vivo Opportunity Fund Holdings, L.P. (Reporting) Vivo Opportunity, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 4:53 PM | Huang Michael F. (Reporting) Soleno Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/30/2024 4:54 PM | Manning Meredith (Reporting) Soleno Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/22/2024 4:06 PM | Soleno Therapeutics (Filer)
| Form ARS | |
04/22/2024 3:31 PM | Soleno Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024 3:15 PM | Soleno Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/03/2024 8:36 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 8:37 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 8:39 PM | Mackaness James H (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 8:40 PM | Soleno Therapeutics (Issuer) Yen Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 5:06 AM | Soleno Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 4:35 PM | JANUS HENDERSON GROUP PLC (Filed by) Soleno Therapeutics (Subject)
| Form SC 13G/A | |
02/07/2024 7:01 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Soleno Therapeutics (Subject)
| Form SC 13G/A | |
01/30/2024 3:57 PM | Soleno Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/29/2024 4:42 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 4:44 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 4:47 PM | Soleno Therapeutics (Issuer) Yen Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 3:31 PM | MARIO ERNEST (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 4:34 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 4:35 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 4:36 PM | Mackaness James H (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 4:37 PM | Soleno Therapeutics (Issuer) Yen Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:16 PM | Soleno Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/15/2023 5:00 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 6:57 PM | Soleno Therapeutics (Issuer) Yen Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 4:09 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023 8:32 PM | Mackaness James H (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 8:32 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 8:34 PM | Mackaness James H (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 8:34 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 3:46 PM | Soleno Therapeutics (Subject) Yen Kristen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023 3:53 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023 5:17 PM | Soleno Therapeutics (Subject) Yen Kristen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023 6:05 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023 6:21 PM | Mackaness James H (Reporting) Soleno Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
12/04/2023 7:41 PM | MARIO ERNEST (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 7:02 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 7:03 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 7:04 PM | Mackaness James H (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 7:06 PM | Soleno Therapeutics (Issuer) Yen Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/30/2023 8:50 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/30/2023 8:51 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/30/2023 8:52 PM | Mackaness James H (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/30/2023 8:52 PM | Soleno Therapeutics (Issuer) Yen Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |